𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Epstein–Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein–Barr virus-carrying natural killer and T cells

✍ Scribed by Ayako Demachi-Okamura; Yoshinori Ito; Yoshiki Akatsuka; Kunio Tsujimura; Yasuo Morishima; Toshitada Takahashi; Kiyotaka Kuzushima

Book ID
108584234
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
551 KB
Volume
99
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Generation of Epstein-Barr virus antigen
Generation of Epstein-Barr virus antigen-specific suppressor T cells in vitro
✍ Syam K. Sundar; José Menezes 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 French ⚖ 653 KB

## Abstract Immunosuppression is a commonly observed phenomenon in Epstein‐Barr virus (EBV)‐associated disorders and malignancies. The purpose of this study was to determine whether EBV antigens could generate suppressor cell activity __in vitro.__ Pepripheral blood lymphocytes (PBL) were first tre

Non-integrating lentiviral vectors for s
Non-integrating lentiviral vectors for specific killing of Epstein–Barr virus nuclear antigen 1-positive B cell lymphoma cells
✍ Ryan P. Flynn; Jeana Zacharias; Xianzheng Zhou; Mark L. Cannon; Nicola J. Philpo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 374 KB 👁 1 views

## Abstract ## Background Epstein–Barr virus (EBV) causes a range of life‐threatening B‐lymphocyte malignancies but, despite the use of various strategies, treatment remains problematic. ## Methods In the present study, we developed a non‐integrating lentiviral vector (NILV) that mediates specif

Patients with Epstein Barr virus-positiv
Patients with Epstein Barr virus-positive lymphomas have decreased CD4+ T-cell responses to the viral nuclear antigen 1
✍ Kevin N. Heller; Frida Arrey; Peter Steinherz; Carol Portlock; Amy Chadburn; Kar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 457 KB 👁 1 views

## Abstract Epstein Barr virus (EBV) causes lymphomas in immune competent and, at increased frequencies, in immune compromised patients. In the presence of an intact immune system, EBV‐associated lymphomas express in most cases only 3 or fewer EBV antigens at the protein level, always including the